| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $621.2M | +47.1% |
| Cost of Revenue | $179.3M | +24.3% |
| Gross Profit | $441.9M | +58.9% |
| R&D Expense | $218.2M | +5.4% |
| SG&A Expense | $198.2M | +21.8% |
| Operating Income | -$378.4M | +6.0% |
| Interest Expense | $1.2M | -33.6% |
| Pre-tax Income | -$332.8M | +13.4% |
| Income Tax | $5.9M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $256.7M | +86.1% |
| Short-term Investments | $669.3M | +37.8% |
| Accounts Receivable | $214.3M | +41.5% |
| Current Assets | $1.30B | +41.8% |
| Total Assets | $2.32B | +2.8% |
| Current Liabilities | $590.1M | +24.7% |
| Total Liabilities | $727.4M | +20.8% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$68.4M | +64.6% |
| Capital Expenditures | $1.3M | -73.7% |
| Investing Cash Flow | $140.6M | +110.7% |
| Financing Cash Flow | $47.5M | +30.7% |
| Free Cash Flow | -$69.7M | +64.9% |
| +204.4% |
| Net Income | -$338.7M | +10.6% |
| EPS (Basic) | -$1.15 | +15.4% |
| EPS (Diluted) | -$1.15 | +15.4% |
| Stockholders' Equity |
| $1.59B |
| -3.8% |